Does Insurance Cover Telehealth Ketamine?

The short answer: for most patients, most insurance plans do not cover at-home telehealth ketamine therapy. But the complete picture is more nuanced—some components may be coverable, some plans are more flexible than others, and the coverage landscape is evolving. This guide provides a realistic, detailed assessment.

Why Insurance Typically Doesn't Cover It

Off-Label Use

The compounded ketamine used in telehealth programs is prescribed off-label. Ketamine is FDA-approved as an anesthetic, not for depression, anxiety, or PTSD. Insurers generally do not cover off-label treatments, particularly when FDA-approved alternatives exist (even if those alternatives have not worked for the patient).

The exception: esketamine (Spravato), the FDA-approved nasal spray for treatment-resistant depression, is covered by many insurance plans for its approved indications—but Spravato is a certified healthcare-setting-only treatment, not part of the at-home telehealth model.

Compounding Pharmacy Issue

Insurance typically covers FDA-approved manufactured drugs dispensed by licensed pharmacies. Compounded medications—including compounded ketamine troches—occupy a different regulatory category. Most pharmacy benefit plans do not cover compounded preparations for off-label use.

No Standard Billing Code

There is no standard ICD-10 diagnosis code for "ketamine treatment for depression" and no universally accepted CPT (Current Procedural Terminology) code for a ketamine infusion as a psychiatric treatment. This makes billing insurance for the treatment itself operationally challenging.

What Might Be Covered by Insurance

The Psychiatric Evaluation

The initial medical evaluation with a licensed clinician (which is ultimately a psychiatric evaluation) may be billable to insurance as a telehealth mental health evaluation. Diagnoses of MDD or PTSD are standard ICD-10 codes that insurance plans cover. Whether a specific insurer will cover the evaluation depends on:

• Whether the provider is in-network
• Whether telehealth is covered for mental health services under your plan
• Whether the claim is submitted with the diagnosis code (not the treatment name)

Ask your telehealth platform whether they can bill the evaluation to insurance. Many cash-pay platforms cannot—they are not enrolled as insurance providers. For a broader comparison of payment models, see our insurance vs. cash pay comparison.

Ongoing Psychiatric Management

If your telehealth ketamine provider bills themselves as a psychiatric management provider and uses standard mental health CPT codes (e.g., 90792 for psychiatric evaluation, 99213-99215 for medication management), some of this care may be reimbursable.

Your Independent Therapist

If you work with an outside therapist for integration (as with the therapist-integration model offered by some platforms), and that therapist is in-network with your insurance, your therapy sessions may be fully or partially covered. This is significant for patients whose total cost includes substantial therapy fees. See our complete cost breakdown guide for typical pricing across platforms.

How to Approach Insurance Reimbursement

Out-of-Network Benefits

If your insurer offers out-of-network (OON) benefits for mental health services, you may be able to submit claims for your telehealth ketamine evaluation and follow-up appointments yourself after receiving superbills from your provider. OON reimbursement is typically partial (50-80% after deductible) and requires more administrative work.

Ask your platform: "Can you provide a superbill I can submit to my insurance for out-of-network reimbursement?"

Prior Authorization for Spravato

If you are also considering esketamine (Spravato) as a covered alternative, the prior authorization process typically requires documentation of:

• Two failed adequate antidepressant trials
• Current severity of depression
• Physician attestation that Spravato is appropriate
• The treating facility being a certified Spravato center

This is a separate pathway from telehealth compounded ketamine but may be worth pursuing in parallel if your diagnosis qualifies.

Appeal Denials

Insurance denials can sometimes be successfully appealed, particularly when:

• Your clinician writes a letter of medical necessity
• You can document that covered treatments have failed
• Your plan's mental health parity obligations apply

Mental health parity law (the Mental Health Parity and Addiction Equity Act) requires that insurers apply the same standards to mental health benefits as to medical/surgical benefits. If your insurer covers experimental medical treatments in some contexts but denies all experimental mental health treatments categorically, that may be a parity violation worth pursuing.

Relevant Billing Codes to Know

ICD-10 Diagnosis Codes:

• F32.2: Major depressive disorder, single episode, severe without psychotic features
• F33.2: Major depressive disorder, recurrent, severe without psychotic features
• F43.10: Post-traumatic stress disorder, unspecified
• F41.1: Generalized anxiety disorder

CPT Codes Potentially Applicable:

• 99213-99215: Office or other outpatient E&M services (medication management)
• 99242-99244: Office consultation
• 90792: Psychiatric evaluation with medical services
• 90834: Individual psychotherapy, 45 minutes
• 96150-96155: Health and behavior assessment/intervention codes

No CPT code specifically for ketamine administration exists in the standard AMA CPT code set for outpatient off-label psychiatric use.

The Longer-Term Coverage Outlook

Insurance coverage for ketamine therapy is likely to expand over the next 5-10 years as:

• Clinical evidence continues to accumulate
• FDA guidance or approval for additional ketamine indications develops
• Mental health parity enforcement intensifies
• Payers recognize the cost savings from effective treatment of treatment-resistant depression compared to ongoing treatment attempts and hospitalizations

Some self-funded employer health plans—which have more flexibility than fully insured plans—have already begun covering ketamine treatment for selected employees through supplemental mental health benefits. This trend may expand.

For now, most patients should plan on self-pay and use the FSA/HSA and superbill strategies described above to partially offset costs.

References

• StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
• PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
• MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
• HHS: Telehealth — U.S. Department of Health and Human Services guide to telehealth services, regulations, and patient resources
• SAMHSA: National Helpline — Substance Abuse and Mental Health Services Administration free treatment referral and information service